Home > Publications database > Status epilepticus during the COVID-19 pandemic in Cologne, Germany: data from a retrospective, multicentre registry > print |
001 | 909612 | ||
005 | 20230217124535.0 | ||
024 | 7 | _ | |a 10.1007/s00415-022-11260-2 |2 doi |
024 | 7 | _ | |a 0012-1037 |2 ISSN |
024 | 7 | _ | |a 0340-5354 |2 ISSN |
024 | 7 | _ | |a 0939-1517 |2 ISSN |
024 | 7 | _ | |a 1432-1459 |2 ISSN |
024 | 7 | _ | |a 1619-800X |2 ISSN |
024 | 7 | _ | |a 2128/33059 |2 Handle |
024 | 7 | _ | |a 35802201 |2 pmid |
024 | 7 | _ | |a WOS:000822252300001 |2 WOS |
037 | _ | _ | |a FZJ-2022-03284 |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Kohle, Felix |0 0000-0002-4429-0367 |b 0 |e Corresponding author |
245 | _ | _ | |a Status epilepticus during the COVID-19 pandemic in Cologne, Germany: data from a retrospective, multicentre registry |
260 | _ | _ | |a Berlin |c 2022 |b Springer |
264 | _ | 1 | |3 online |2 Crossref |b Springer Science and Business Media LLC |c 2022-07-08 |
264 | _ | 1 | |3 print |2 Crossref |b Springer Science and Business Media LLC |c 2022-11-01 |
264 | _ | 1 | |3 print |2 Crossref |b Springer Science and Business Media LLC |c 2022-11-01 |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1670912913_32695 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
536 | _ | _ | |a 5251 - Multilevel Brain Organization and Variability (POF4-525) |0 G:(DE-HGF)POF4-5251 |c POF4-525 |f POF IV |x 0 |
542 | _ | _ | |i 2022-07-08 |2 Crossref |u https://creativecommons.org/licenses/by/4.0 |
542 | _ | _ | |i 2022-07-08 |2 Crossref |u https://creativecommons.org/licenses/by/4.0 |
588 | _ | _ | |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de |
700 | 1 | _ | |a Madlener, Marie |0 P:(DE-HGF)0 |b 1 |
700 | 1 | _ | |a Bruno, Emanuel Francesco |0 P:(DE-HGF)0 |b 2 |
700 | 1 | _ | |a Fink, Gereon Rudolf |0 P:(DE-Juel1)131720 |b 3 |
700 | 1 | _ | |a Limmroth, Volker |0 P:(DE-HGF)0 |b 4 |
700 | 1 | _ | |a Burghaus, Lothar |0 P:(DE-HGF)0 |b 5 |
700 | 1 | _ | |a Malter, Michael Peter |0 P:(DE-HGF)0 |b 6 |e Corresponding author |
773 | 1 | 8 | |a 10.1007/s00415-022-11260-2 |b Springer Science and Business Media LLC |d 2022-07-08 |n 11 |p 5710-5719 |3 journal-article |2 Crossref |t Journal of Neurology |v 269 |y 2022 |x 0340-5354 |
773 | _ | _ | |a 10.1007/s00415-022-11260-2 |g Vol. 269, no. 11, p. 5710 - 5719 |0 PERI:(DE-600)1421299-7 |n 11 |p 5710-5719 |t Journal of neurology |v 269 |y 2022 |x 0340-5354 |
856 | 4 | _ | |u https://juser.fz-juelich.de/record/909612/files/FINK__Kohle_2022_Journal%20of%20Neurology_Status%20epilepticus%20during%20COVID-19%20pandemic%20in%20Cologne.pdf |y OpenAccess |
909 | C | O | |o oai:juser.fz-juelich.de:909612 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 3 |6 P:(DE-Juel1)131720 |
913 | 1 | _ | |a DE-HGF |b Key Technologies |l Natural, Artificial and Cognitive Information Processing |1 G:(DE-HGF)POF4-520 |0 G:(DE-HGF)POF4-525 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-500 |4 G:(DE-HGF)POF |v Decoding Brain Organization and Dysfunction |9 G:(DE-HGF)POF4-5251 |x 0 |
914 | 1 | _ | |y 2022 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b J NEUROL : 2015 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |
915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
920 | _ | _ | |l yes |
920 | 1 | _ | |0 I:(DE-Juel1)INM-3-20090406 |k INM-3 |l Kognitive Neurowissenschaften |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a UNRESTRICTED |
980 | _ | _ | |a I:(DE-Juel1)INM-3-20090406 |
980 | 1 | _ | |a FullTexts |
999 | C | 5 | |a 10.1046/j.1528-1157.2001.01101.x |9 -- missing cx lookup -- |1 S Knake |p 714 - |2 Crossref |u Knake S, Rosenow F, Vescovi M, Oertel WH, Mueller HH, Wirbatz A, Katsarou N, Hamer HM (2001) Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia 42:714–718 |t Epilepsia |v 42 |y 2001 |
999 | C | 5 | |a 10.1111/epi.13121 |9 -- missing cx lookup -- |1 E Trinka |p 1515 - |2 Crossref |u Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, Shorvon S, Lowenstein DH (2015) A definition and classification of status epilepticus—report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia 56:1515–1523 |t Epilepsia |v 56 |y 2015 |
999 | C | 5 | |a 10.1212/WNL.46.4.1029 |9 -- missing cx lookup -- |1 RJ DeLorenzo |p 1029 - |2 Crossref |u DeLorenzo RJ, Hauser WA, Towne AR, Boggs JG, Pellock JM, Penberthy L, Garnett L, Fortner CA, Ko D (1996) A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 46:1029–1035 |t Neurology |v 46 |y 1996 |
999 | C | 5 | |a 10.1016/S1473-3099(20)30120-1 |9 -- missing cx lookup -- |1 E Dong |p 533 - |2 Crossref |u Dong E, Du H, Gardner L (2020) An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis 20:533–534 |t Lancet Infect Dis |v 20 |y 2020 |
999 | C | 5 | |a 10.1056/NEJMoa2001017 |9 -- missing cx lookup -- |1 N Zhu |p 727 - |2 Crossref |u Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727–733 |t N Engl J Med |v 382 |y 2020 |
999 | C | 5 | |a 10.1016/S0140-6736(20)30183-5 |9 -- missing cx lookup -- |1 C Huang |p 497 - |2 Crossref |u Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497–506 |t Lancet |v 395 |y 2020 |
999 | C | 5 | |a 10.1038/s41467-020-19509-y |9 -- missing cx lookup -- |1 H Streeck |p 5829 - |2 Crossref |u Streeck H, Schulte B, Kümmerer BM, Richter E, Höller T, Fuhrmann C, Bartok E, Dolscheid-Pommerich R, Berger M, Wessendorf L, Eschbach-Bludau M, Kellings A, Schwaiger A, Coenen M, Hoffmann P, Stoffel-Wagner B, Nöthen MM, Eis-Hübinger AM, Exner M, Schmithausen RM, Schmid M, Hartmann G (2020) Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany. Nat Commun 11:5829 |t Nat Commun |v 11 |y 2020 |
999 | C | 5 | |a 10.1016/S2213-2600(21)00101-6 |9 -- missing cx lookup -- |1 C Karagiannidis |p e47 - |2 Crossref |u Karagiannidis C, Windisch W, McAuley DF, Welte T, Busse R (2021) Major differences in ICU admissions during the first and second COVID-19 wave in Germany. Lancet Respir Med 9:e47–e48 |t Lancet Respir Med |v 9 |y 2021 |
999 | C | 5 | |a 10.1016/j.lanepe.2021.100151 |9 -- missing cx lookup -- |1 A Schuppert |p 100151 - |2 Crossref |u Schuppert A, Polotzek K, Schmitt J, Busse R, Karschau J, Karagiannidis C (2021) Different spreading dynamics throughout Germany during the second wave of the COVID-19 pandemic: a time series study based on national surveillance data. Lancet Reg Health Eur 6:100151–100151 |t Lancet Reg Health Eur |v 6 |y 2021 |
999 | C | 5 | |a 10.1161/STROKEAHA.120.033160 |9 -- missing cx lookup -- |1 D Richter |p 716 - |2 Crossref |u Richter D, Eyding J, Weber R, Bartig D, Grau A, Hacke W, Krogias C (2021) Analysis of nationwide stroke patient care in times of COVID-19 pandemic in Germany. Stroke 52:716–721 |t Stroke |v 52 |y 2021 |
999 | C | 5 | |a 10.1161/STROKEAHA.120.030792 |9 -- missing cx lookup -- |1 D Aguiar de Sousa |p 1921 - |2 Crossref |u Aguiar de Sousa D, Sandset EC, Elkind MSV (2020) The curious case of the missing strokes during the COVID-19 pandemic. Stroke 51:1921–1923 |t Stroke |v 51 |y 2020 |
999 | C | 5 | |a 10.1186/s42466-020-00097-7 |9 -- missing cx lookup -- |1 P Berlit |p 51 - |2 Crossref |u Berlit P, Bösel J, Gahn G, Isenmann S, Meuth SG, Nolte CH, Pawlitzki M, Rosenow F, Schoser B, Thomalla G, Hummel T (2020) “Neurological manifestations of COVID-19”—guideline of the German society of neurology. Neurol Res Pract 2:51 |t Neurol Res Pract |v 2 |y 2020 |
999 | C | 5 | |a 10.3988/jcn.2021.17.3.435 |9 -- missing cx lookup -- |1 HK Kim |p 435 - |2 Crossref |u Kim HK, Cho YJ, Lee SY (2021) Neurological manifestations in patients with COVID-19: experiences from the central infectious diseases hospital in South Korea. J Clin Neurol 17:435–442 |t J Clin Neurol |v 17 |y 2021 |
999 | C | 5 | |a 10.1007/s10072-020-04932-2 |9 -- missing cx lookup -- |1 AA Asadi-Pooya |p 415 - |2 Crossref |u Asadi-Pooya AA, Simani L, Shahisavandi M, Barzegar Z (2021) COVID-19, de novo seizures, and epilepsy: a systematic review. Neurol Sci 42:415–431 |t Neurol Sci |v 42 |y 2021 |
999 | C | 5 | |a 10.1212/WNL.0000000000009632 |9 -- missing cx lookup -- |1 JA French |p 1032 - |2 Crossref |u French JA, Brodie MJ, Caraballo R, Devinsky O, Ding D, Jehi L, Jette N, Kanner A, Modi AC, Newton CR, Patel AA, Pennell PB, Perucca E, Sander JW, Scheffer IE, Singh G, Williams E, Wilmshurst J, Cross JH (2020) Keeping people with epilepsy safe during the COVID-19 pandemic. Neurology 94:1032–1037 |t Neurology |v 94 |y 2020 |
999 | C | 5 | |a 10.1177/1535759720956994 |9 -- missing cx lookup -- |1 DVF Albert |p 316 - |2 Crossref |u Albert DVF, Das RR, Acharya JN, Lee JW, Pollard JR, Punia V, Keller JA, Husain AM (2020) The Impact of COVID-19 on epilepsy care: a survey of the American epilepsy society membership. Epilepsy Curr 20:316–324 |t Epilepsy Curr |v 20 |y 2020 |
999 | C | 5 | |1 M Belluzzo |y 2021 |2 Crossref |u Belluzzo M, Nilo A, Valente M, Gigli GL (2021) New-onset status epilepticus in SARS-CoV-2 infection: a case series. Neurol Sci 2021:1–6 |
999 | C | 5 | |a 10.1111/epi.12270 |9 -- missing cx lookup -- |1 S Beniczky |p 28 - |2 Crossref |u Beniczky S, Hirsch LJ, Kaplan PW, Pressler R, Bauer G, Aurlien H, Brøgger JC, Trinka E (2013) Unified EEG terminology and criteria for nonconvulsive status epilepticus. Epilepsia 54(Suppl 6):28–29 |t Epilepsia |v 54 |y 2013 |
999 | C | 5 | |a 10.1177/003693305700200504 |9 -- missing cx lookup -- |1 J Rankin |p 200 - |2 Crossref |u Rankin J (1957) Cerebral vascular accidents in patients over the age of 60: II. Prognosis. Scottish Med J 2:200–215 |t Scottish Med J |v 2 |y 1957 |
999 | C | 5 | |a 10.1161/01.STR.19.5.604 |9 -- missing cx lookup -- |1 JC van Swieten |p 604 - |2 Crossref |u van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19:604–607 |t Stroke |v 19 |y 1988 |
999 | C | 5 | |a 10.1007/s12028-014-0080-y |9 -- missing cx lookup -- |1 M Leitinger |p 273 - |2 Crossref |u Leitinger M, Höller Y, Kalss G, Rohracher A, Novak HF, Höfler J, Dobesberger J, Kuchukhidze G, Trinka E (2015) Epidemiology-based mortality score in status epilepticus (EMSE). Neurocrit Care 22:273–282 |t Neurocrit Care |v 22 |y 2015 |
999 | C | 5 | |a 10.1016/j.eplepsyres.2017.07.006 |9 -- missing cx lookup -- |1 R-J Lv |p 12 - |2 Crossref |u Lv R-J, Wang Q, Cui T, Zhu F, Shao X-Q (2017) Status epilepticus-related etiology, incidence and mortality: a meta-analysis. Epilepsy Res 136:12–17 |t Epilepsy Res |v 136 |y 2017 |
999 | C | 5 | |a 10.1212/WNL.50.3.735 |9 -- missing cx lookup -- |1 DC Hesdorffer |p 735 - |2 Crossref |u Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA (1998) Incidence of status epilepticus in Rochester, Minnesota, 1965–1984. Neurology 50:735–741 |t Neurology |v 50 |y 1998 |
999 | C | 5 | |a 10.1016/S1474-4422(15)00042-3 |9 -- missing cx lookup -- |1 JP Betjemann |p 615 - |2 Crossref |u Betjemann JP, Lowenstein DH (2015) Status epilepticus in adults. Lancet Neurol 14:615–624 |t Lancet Neurol |v 14 |y 2015 |
999 | C | 5 | |2 Crossref |u Koeln S (2021) Bevölkerungszahl sinkt leicht auf 1 088 040 in 2020. Available from: https://www.stadt-koeln.de/mediaasset/content/pdf15/statistik-einwohner-und-haushalte/kurzinformation_bev%C3%B6lkerung_3_2021.pdf |
999 | C | 5 | |a 10.1016/j.seizure.2014.06.009 |9 -- missing cx lookup -- |1 D Bhalla |p 769 - |2 Crossref |u Bhalla D, Tchalla AE, Mignard C, Marin B, Mignard D, Jallon P, Preux P-M (2014) First-ever population-based study on status epilepticus in French Island of La Reunion (France)—incidence and fatality. Seizure 23:769–773 |t Seizure |v 23 |y 2014 |
999 | C | 5 | |a 10.1159/000111873 |9 -- missing cx lookup -- |1 V Govoni |p 120 - |2 Crossref |u Govoni V, Fallica E, Monetti VC, Guerzoni F, Faggioli R, Casetta I, Granieri E (2008) Incidence of status epilepticus in Southern Europe: a population study in the Health District of Ferrara, Italy. Eur Neurol 59:120–126 |t Eur Neurol |v 59 |y 2008 |
999 | C | 5 | |a 10.1111/epi.14607 |9 -- missing cx lookup -- |1 M Leitinger |p 53 - |2 Crossref |u Leitinger M, Trinka E, Giovannini G, Zimmermann G, Florea C, Rohracher A, Kalss G, Neuray C, Kreidenhuber R, Höfler J, Kuchukhidze G, Granbichler C, Dobesberger J, Novak HF, Pilz G, Meletti S, Siebert U (2019) Epidemiology of status epilepticus in adults: a population-based study on incidence, causes, and outcomes. Epilepsia 60:53–62 |t Epilepsia |v 60 |y 2019 |
999 | C | 5 | |a 10.1097/00004691-199512040-00003 |9 -- missing cx lookup -- |1 RJ DeLorenzo |p 316 - |2 Crossref |u DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG (1995) Epidemiology of status epilepticus. J Clin Neurophysiol 12:316–325 |t J Clin Neurophysiol |v 12 |y 1995 |
999 | C | 5 | |a 10.1111/epi.16277 |9 -- missing cx lookup -- |1 PS Bergin |p 1552 - |2 Crossref |u Bergin PS, Brockington A, Jayabal J, Scott S, Litchfield R, Roberts L, Timog J, Beilharz E, Dalziel SR, Jones P, Yates K, Thornton V, Walker EB, Davis S, Te Ao B, Parmar P, Beghi E, Rossetti AO, Feigin V (2019) Status epilepticus in Auckland, New Zealand: incidence, etiology, and outcomes. Epilepsia 60:1552–1564 |t Epilepsia |v 60 |y 2019 |
999 | C | 5 | |1 G Pauletto |y 2021 |2 Crossref |u Pauletto G, Nilo A, Deana C, Verriello L, Del Negro I, Lettieri C, Vetrugno L, Valente M, Gigli GL (2021) Recurrent status epilepticus and SARS-CoV-2 infection: the “perfect storm.” Acta Biomed 92:e2021208 |
999 | C | 5 | |a 10.1111/epi.16737 |9 -- missing cx lookup -- |1 M Leitinger |p e198 - |2 Crossref |u Leitinger M, Poppert KN, Mauritz M, Rossini F, Zimmermann G, Rohracher A, Kalss G, Kuchukhidze G, Höfler J, Bosque Varela P, Kreidenhuber R, Volna K, Neuray C, Kobulashvili T, Granbichler CA, Siebert U, Trinka E (2020) Status epilepticus admissions during the COVID-19 pandemic in Salzburg-A population-based study. Epilepsia 61:e198–e203 |t Epilepsia |v 61 |y 2020 |
999 | C | 5 | |a 10.1016/j.yebeh.2021.107833 |9 -- missing cx lookup -- |1 TM Mueller |p 107833 - |2 Crossref |u Mueller TM, Kostev K, Gollwitzer S, Lang JD, Stritzelberger J, Westermayer V, Reindl C, Hamer HM (2021) The impact of the coronavirus disease (COVID-19) pandemic on outpatient epilepsy care: an analysis of physician practices in Germany. Epilepsy Behav 117:107833–107833 |t Epilepsy Behav |v 117 |y 2021 |
999 | C | 5 | |a 10.1111/epi.17045 |9 -- missing cx lookup -- |1 JH Cross |p 2322 - |2 Crossref |u Cross JH, Kwon CS, Asadi-Pooya AA, Balagura G, Gómez-Iglesias P, Guekht A, Hall J, Ikeda A, Kishk NA, Murphy P, Kissani N, Naji Y, Perucca E, Pérez-Poveda JC, Sanya EO, Trinka E, Zhou D, Wiebe S, Jette N (2021) Epilepsy care during the COVID-19 pandemic. Epilepsia 62:2322–2332 |t Epilepsia |v 62 |y 2021 |
999 | C | 5 | |a 10.3389/fneur.2020.00737 |9 -- missing cx lookup -- |1 G Assenza |p 737 - |2 Crossref |u Assenza G, Lanzone J, Brigo F, Coppola A, Di Gennaro G, Di Lazzaro V, Ricci L, Romigi A, Tombini M, Mecarelli O (2020) Epilepsy care in the time of COVID-19 Pandemic in Italy: risk factors for seizure Worsening. Front Neurol 11:737 |t Front Neurol |v 11 |y 2020 |
999 | C | 5 | |a 10.1056/NEJMc2014816 |9 -- missing cx lookup -- |1 AP Kansagra |p 400 - |2 Crossref |u Kansagra AP, Goyal MS, Hamilton S, Albers GW (2020) Collateral effect of Covid-19 on stroke evaluation in the United States. N Engl J Med 383:400–401 |t N Engl J Med |v 383 |y 2020 |
999 | C | 5 | |1 D Schöppenthau |y 2021 |2 Crossref |u Schöppenthau D, Weiß KJ, Estepa-Martinez M, Hommel M, Miera O, Schoenrath F, Hübler S, Obermeier M, Pieske B, Stawowy P (2021) Preventing SARS-CoV-2 in-hospital infections in cardiovascular patients and medical staff: an observational study from the German Heart Center Berlin. Front Med 2021:7 |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|